How to Buy Bausch & Lomb Stock
Bausch & Lomb Corp
Bausch & Lomb is a medical company located in British Columbia, Canada, which is part of the Healthcare sector, and is traded under the ticker BLCO on the NYSE exchange.
Bausch & Lomb stock last closed at $15.35, up 1.05% from the previous day, and has decreased 3.28% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.06 percentage points. Bausch & Lomb stock is currently +16.64% from its 52-week low of $13.16, and -29.23% from its 52-week high of $21.69.
As of Mar 14, 2025, there are 352.47M shares of BLCO outstanding. The market capitalization of BLCO is $5.41B. In the last 24 hours, 278,286 BLCO shares were traded.
How to Buy Bausch & Lomb Stock
Wondering how to invest in Bausch & Lomb stock? Here's how.
- Choose where to buy Bausch & Lomb stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Bausch & Lomb stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Select your method of payment and add your details.
- Evaluate Bausch & Lomb stock: The Bausch & Lomb ticker symbol is BLCO. Is Bausch & Lomb stock a good investment? Should you buy shares of BLCO? How do BLCO's underlying business fundamentals look? Do top analysts think Bausch & Lomb is a good buy? Why has BLCO's stock price moved recently? (Hint: Our stock market research website can help you decide if BLCO is a good stock to buy).
- Make your BLCO purchase: Decide if you will purchase BLCO shares at the current market price or use a limit order to purchase BLCO stock at a given price.
- Track your BLCO position: Create a watchlist to track your investment in Bausch & Lomb stock.
Step 1: Choose where to buy Bausch & Lomb stock
You need a brokerage account to access the NYSE market and buy BLCO shares.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to buy BLCO today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create a new brokerage account.
- Send your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've filled out your info on stock apps to use, you can securely and quickly fund your account:
Check out the tutorial below if you need help transferring money into your brokerage account.
Step 4: Evaluate Bausch & Lomb stock
After you have selected the best place to buy Bausch & Lomb stock, it's absolutely critical to analyze their stock prior to buying, so you truly understand the risk as well as the upside.
Bausch & Lomb stock data
Bausch & Lomb Fundamentals
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on BLCO's stock page.
What is the fair value of BLCO stock?
Analysts use many financial metrics, analyses, models, and charts to gauge BLCO's fair value.
Using relative valuations ratios:
- BLCO may be undervalued based on its P/B ratio of 0.84x, relative to Medical Instruments & Supplies industry P/B ratio of 3.69x
You can access additional valuation analysis on BLCO's stock here.
BLCO Financial Health
Signs that BLCO is financially healthy:
- There are more short-term assets than short-term liabilities on the BLCO balance sheet.
- BLCO has cash burn of 59000000. It has enough cash and short-term investments to cover this for at least one year.
- BLCO has $316.00M in cash and short term investments. This is enough to cover its annual cash burn of $59.00M.
Signs that BLCO is not financially healthy:
- BLCO has a relatively high debt to equity ratio of 1.07.
- There are more long-term liabilities than short-term assets on the BLCO balance sheet.
- BLCO profit margin has gone down from -6.3% to -6.6% in the past year.
Is it a good time to buy Bausch & Lomb stock, according to analysts?
Out of 8 sell side analysts who give recommendations on BLCO, the consensus analyst rating on Bausch & Lomb is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest BLCO Analyst Recommendations
Joanne Wuensch, a top 7% analyst from Citigroup downgrades BLCO to a hold rating and lowers their BLCO price target from $24.00 to $22.00, on Dec 11, 2024.
Patrick Wood, a top 16% analyst from Morgan Stanley downgrades BLCO to a hold rating and announces their BLCO price target of $19.00, on Dec 2, 2024.
Vijay Kumar, a bottom 6% analyst from Evercore ISI Group upgrades BLCO to a buy rating and raises their BLCO price target from $19.00 to $25.00, on Oct 15, 2024.
You can dive deeper into what analysts are projecting on the Bausch & Lomb stock forecast page.
BLCO Momentum
BLCO Revenue
Last year, BLCO revenue was $4.79B. During the past five year, BLCO's revenue has increased by 4.87% per year. This was slower than the Medical Instruments & Supplies industry average of 8.95%.
Dig into BLCO's earnings and revenue performance here.
Latest Insiders Trades at BLCO
Over the last year, insiders at BLCO have sold more shares than they have bought.
Luc Bonnefoy, PresidentSurgical of BLCO, was the latest BLCO insider to sell. They sold $17,760.00 worth of BLCO shares on Feb 28, 2025.
Get more info about who owns BLCO shares here.
Does BLCO provide a stable income stream?
No, Bausch & Lomb doesn't provide an income stream by paying out dividends.
What others are saying about BLCO
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your BLCO purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount limit, place a limit order.
Press the Open button and eToro will execute your order.
If you require more info about investing in stocks on eToro, click the how to video below:
Step 6: Track your BLCO position
Now that you own some shares in BLCO, you'll want to stay up-to-date on your new company.
Create a watchlist to track your BLCO stock.
BLCO Feed
How to Buy Stock in Bausch & Lomb
To summarize, here are the 6 steps you need to take to buy Bausch & Lomb stock right now:
- Choose where to buy Bausch & Lomb stock
- Create a brokerage account
- Put funds into your investment account
- Evaluate Bausch & Lomb stock
- Make your BLCO purchase
- Track your BLCO position
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Bausch & Lomb, click the button below.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.